Telomir Pharmaceuticals Inc (TELO)
6.30
-0.44
(-6.53%)
USD |
NASDAQ |
May 28, 15:02
Telomir Pharmaceuticals Price to Book Value: 61.84 for May 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 66.16 |
| May 23, 2024 | 61.84 |
| May 22, 2024 | 54.97 |
| May 21, 2024 | 55.95 |
| May 20, 2024 | 59.29 |
| May 17, 2024 | 60.66 |
| May 16, 2024 | 60.68 |
| May 15, 2024 | 60.96 |
| May 14, 2024 | 61.89 |
| May 13, 2024 | 65.37 |
| May 10, 2024 | 67.83 |
| May 09, 2024 | 64.19 |
| May 08, 2024 | 58.21 |
| May 07, 2024 | 61.64 |
| May 06, 2024 | 59.39 |
| May 03, 2024 | 60.86 |
| May 02, 2024 | 67.14 |
| May 01, 2024 | 66.99 |
| April 30, 2024 | 64.98 |
| April 29, 2024 | 71.36 |
| April 26, 2024 | 67.38 |
| April 25, 2024 | 66.75 |
| April 24, 2024 | 68.42 |
| April 23, 2024 | 57.13 |
| April 22, 2024 | 55.02 |
| Date | Value |
|---|---|
| April 19, 2024 | 78.38 |
| April 18, 2024 | 78.04 |
| April 17, 2024 | 83.24 |
| April 16, 2024 | 82.16 |
| April 15, 2024 | 86.77 |
| April 12, 2024 | 88.34 |
| April 11, 2024 | 80.49 |
| April 10, 2024 | 75.48 |
| April 09, 2024 | 67.24 |
| April 08, 2024 | 65.86 |
| April 05, 2024 | 69.69 |
| April 04, 2024 | 71.75 |
| April 03, 2024 | 54.53 |
| April 02, 2024 | 53.94 |
| April 01, 2024 | 53.59 |
| March 28, 2024 | 44.35 |
| March 27, 2024 | 43.79 |
| March 26, 2024 | 47.88 |
| March 25, 2024 | 47.80 |
| March 22, 2024 | 55.89 |
| March 21, 2024 | 58.48 |
| March 20, 2024 | 56.84 |
| March 19, 2024 | 51.24 |
| March 18, 2024 | 41.60 |
| March 15, 2024 | 49.35 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
41.60
Minimum
Mar 18 2024
102.48
Maximum
Feb 14 2024
65.71
Average
65.37
Median
May 13 2024
Price to Book Value Benchmarks
| Bio-Path Holdings Inc | -- |
| Hepion Pharmaceuticals Inc | 1.071 |
| Annexon Inc | 1.726 |
| Inhibikase Therapeutics Inc | 2.093 |
| RenovoRx Inc | 17.08 |
Price to Book Value Related Metrics
| Price | 6.30 |
| Earnings Yield | -10.40% |
| Market Cap | 186.54M |